GlassScriptPhysician profile
David J Berger
NPI 1871591677
$6,587.52
in general payments reported to CMS, 2019-2025
36 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $55.78 · 2021: $212 · 2022: $684 · 2023: $1,217 · 2024: $2,437 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,259 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,259.24 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,200.80 | 2021-2025 | Skyrizi, Rinvoq |
| Novo Nordisk INC | $992.78 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $440.65 | 2020-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $314.02 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $279.66 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $243.50 | 2024-2025 | Voquezna |
| Amgen INC. | $239.95 | 2019-2024 | Evenity, Prolia |
| Abbott Laboratories | $186.59 | 2019-2025 | Freestyle Libre 3 |
| Braintree Laboratories, INC. | $170.91 | 2022-2024 | Sutab, Suflave |
| Lilly USA, LLC | $147.04 | 2025 | Mounjaro, Omvoh, Zepbound |
| Genzyme Corporation | $127.17 | 2023-2024 | |
| Exact Sciences Corporation | $126.71 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $126.37 | 2020-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $123.06 | 2019-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Janssen Biotech, INC. | $113.17 | 2024-2025 | Tremfya, Stelara |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $104.25 | 2023-2025 | Entyvio |
| Sanofi-Aventis U.S. LLC | $81.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.58 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $54.54 | 2024-2025 | Vowst |
| Regeneron Healthcare Solutions, INC. | $47.86 | 2023-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.60 | 2022-2024 | Ofev |
| Gilead Sciences, INC. | $38.96 | 2019 | |
| Althera Pharmaceuticals LLC | $37.44 | 2021 | |
| Dynavax Technologies Corporation | $35.71 | 2021-2024 | Heplisav-B |
| Qol Medical, LLC | $30.66 | 2025 | Sucraid |
| Ferring Pharmaceuticals INC. | $25.61 | 2019 | |
| Celltrion USA INC. | $25.00 | 2024 | Zymfentra |
| Dermira, INC. | $23.76 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $21.19 | 2025 | Iqirvo |
| Redhill Biopharma INC. | $19.83 | 2024 | Talicia |
| Almatica Pharma LLC | $18.16 | 2025 | Loreev Xr |
| Ardelyx, INC. | $16.71 | 2024 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $14.72 | 2024 | Breztri |
| Shield Therapeutics INC | $14.32 | 2025 | |
| Cook Medical LLC | $12.90 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.